Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Mifepristone Access
  • Gun Violence Trauma
  • Maternal Mortality
  • Hospital Food
  • Medicaid Work Requirements
  • Visa Program Delays

TRENDING TOPICS:

  • Mifepristone Access
  • Gun Violence Trauma
  • Maternal Mortality
  • Hospital Food
  • Medicaid Work Requirements
  • Visa Program Delays

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jan 14 2021

Full Issue

Viewpoints: Dangers Of Vaccine Nationalism; Pros, Cons Of Relief Checks; Failings Of State Vaccine Rollouts

Editorial pages focus on these pandemic topics and others.

Stat: With Covid-19, 'Vaccine Nationalism' Is A Worrisome Trend 

Just after New Year’s Day, regulators in India granted authorization for restricted use to Bharat Biotech’s Covaxin, adding another Covid-19 vaccine to the list of those that have been approved for use in various countries around the world. New vaccines against Covid-19 are sorely needed worldwide, especially in low-income countries, which are being left behind as high-income countries adopt “vaccine nationalism” and snatch up doses at the expense of those with less means. (Patrick Ho, 1/14)

The Washington Post: Covid-19 Relief: $2,000 Checks Are Not As Progressive As Targeted Aid

President Trump's term is ending in utter disgrace thanks to his countenancing of mob violence against Congress. How ironic, then, that Congress might nevertheless embrace one of Mr. Trump’s policy proposals after Jan. 20, and do so at the initiative of the Democrats who will soon control both chambers. We refer to $2,000 direct payments to U.S. households, which Mr. Trump belatedly demanded as a condition of his signature on the $908 billion bipartisan stimulus package in late December, before being forced to back down in the face of resistance from Senate Majority Leader Mitch McConnell (R-Ky.). (1/13)

The Hill: COVID-19 Vaccines: Good Intent Must Come With Good Strategy 

The past few weeks have been highlighted by the initial rollout of the COVID-19 Moderna and Pfizer vaccinations. Last week, the Biden administration announced their intent to release available vaccination doses to facilitate widespread immunization and curtail rates of spread of the disease. As emergency medicine physicians, we have reasons to celebrate. (Christopher Payette and Janice Blanchard, 1/12)

Miami Herald: Amid Widespread Infection, Florida Gov. DeSantis Fails On COVID Vaccine, Too

The next logical step in the coronavirus nightmare was a vaccination program, so why is Florida in a distribution crisis with fewer vaccines on hand than a state this size demands? Why is there not a logical appointment system that works for everyone? The finger-pointing leads to the federal government, which distributes vaccines to the states. But the responsibility in Florida for the lack of an early, clear and coherent distribution plan lies with one man, the governor. (Fabiola Santiago, 1/13)

The Oregonian: State’s Vaccine Priority Plan A Barrier To Herd Immunity

Life won’t return to normal until enough people are immunized, limiting COVID-19 spread. This “herd immunity” approach takes on greater importance with the identification of new Coronavirus strains that are even more contagious. If these new strains become prevalent, more people will need to be immunized to limit person-to-person disease spread. (Linn Goldberg and Louis Speizer, 1/13)

Atlanta Journal Constitution: A Rocky Path On Covid Vaccine Rollout

COVID-19 has confounded our state from the beginning. And now, as we enter the crucial phase of vaccinating Georgia’s citizens, hopes for a smooth, well-understood and reliable effort have been quickly dashed. (1/13)

Des Moines Register: COVID-19 Demonstrated The Importance Of People At UIHC

All around our hospital, you see the signs: “We Stand Together.” It’s the motto we adopted at University of Iowa Health Care when the coronavirus hit us hard. I was working as a physician assistant in the emergency room when the first COVID-19 patients came through our door. As the trickle of patients turned into a flood, we worried the hospital would be overwhelmed. But our team came together. Colleagues with their skin rubbed raw by PPE kept standing strong, and together we cared for Iowa. We, the 4,000 union nurses and health care professionals of UIHC, have learned from this pandemic that we are better together. Today, as we begin negotiations for a new union contract, we’re bringing that lesson with us to the bargaining table. (Michele Whaylen, 1/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF